Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.
Eur Urol Open Sci. 2024 Feb 6;61:37-43. doi: 10.1016/j.euros.2024.01.009. eCollection 2024 Mar.
Eur Urol Open Sci. 2024.
PMID: 38384437
Free PMC article.
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer.
Meijer D, Eppinga WSC, Mohede RM, Vanneste BGL, Meijnen P, Meijer OWM, Daniels LA, van den Bergh RCN, Lont AP, Ettema RH, Oudshoorn FHK, van Leeuwen PJ, van der Poel HG, Donswijk ML, Oprea-Lager DE, Schaake EE, Vis AN.
Meijer D, et al. Among authors: ettema rh.
Eur Urol Oncol. 2022 Apr;5(2):146-152. doi: 10.1016/j.euo.2022.01.001. Epub 2022 Jan 22.
Eur Urol Oncol. 2022.
PMID: 35074282
Free article.
Item in Clipboard
The prognostic value of lymph node staging with prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic lymph node dissection in node-positive patients with prostate cancer.
Meijer D, Ettema RH, van Leeuwen PJ, van der Kwast TH, van der Poel HG, Donswijk ML, Oprea-Lager DE, Bekers EM, Vis AN.
Meijer D, et al. Among authors: ettema rh.
BJU Int. 2023 Mar;131(3):330-338. doi: 10.1111/bju.15881. Epub 2022 Sep 17.
BJU Int. 2023.
PMID: 36069585
Item in Clipboard
The accuracy and intra- and interobserver variability of PSMA PET/CT for the local staging of primary prostate cancer.
Donswijk ML, Ettema RH, Meijer D, Wondergem M, Cheung Z, Bekers EM, van Leeuwen PJ, van den Bergh RCN, van der Poel HG, Vis AN, Oprea-Lager DE.
Donswijk ML, et al. Among authors: ettema rh.
Eur J Nucl Med Mol Imaging. 2024 May;51(6):1741-1752. doi: 10.1007/s00259-024-06594-0. Epub 2024 Jan 26.
Eur J Nucl Med Mol Imaging. 2024.
PMID: 38273003
Free PMC article.
Item in Clipboard
The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.
Luining WI, Hagens MJ, Meijer D, Ringia JB, de Weijer T, Bektas HO, Ettema RH, Knol RJJ, Roeleveld TA, Srbljin S, Weltings S, Koppes JCC, van Moorselaar RJA, van Leeuwen PJ, Oprea-Lager DE, Vis AN.
Luining WI, et al. Among authors: ettema rh.
Eur Urol Open Sci. 2023 Dec 22;59:55-62. doi: 10.1016/j.euros.2023.12.001. eCollection 2024 Jan.
Eur Urol Open Sci. 2023.
PMID: 38298765
Free PMC article.
Item in Clipboard
A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.
Luining WI, Boevé LMS, Hagens MJ, Meijer D, de Weijer T, Ettema RH, Knol RJJ, Roeleveld TA, Srbljin S, Weltings S, Koppes JCC, van Moorselaar RJA, van Leeuwen PJ, Cysouw MCF, Oprea-Lager DE, Vis AN.
Luining WI, et al. Among authors: ettema rh.
Eur Urol Oncol. 2024 Apr 30:S2588-9311(24)00097-X. doi: 10.1016/j.euo.2024.04.005. Online ahead of print.
Eur Urol Oncol. 2024.
PMID: 38693019
Free article.
Item in Clipboard
Cite
Cite